Sooma Oy

Curated by Signal

Non-invasive neuromodulation therapies

Life Sciences Technologysoomamedical.com

Overview

Sooma Oy is developing a non-invasive brain stimulation device, a treatment option for major neurological and psychiatric disorders. Initial product tDCS targets major depressive disorder and is CE Marked.

Key facts

Founded: 2013
Headquarters: Helsinki, Finland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

PrimerDigital
Provider of primer design software for biotech research applications
Life Sciences TechnologyHelsinki, Finland
DataSolu
Provides a platform for drug discovery
Life Sciences TechnologyKangasala, Finland
GlucoModicum
Provider of wearable devices for blood glucose monitoring
Life Sciences TechnologyHelsinki, Finland

About Sooma Oy

What does Sooma Oy do?

Sooma Oy is developing a non-invasive brain stimulation device, a treatment option for major neurological and psychiatric disorders.

Where is Sooma Oy headquartered?

Sooma Oy is headquartered in Helsinki, Finland.

When was Sooma Oy founded?

Sooma Oy was founded in 2013.

Which sector is Sooma Oy in?

Sooma Oy operates in Life Sciences Technology.

Who are Sooma Oy's competitors?

Companies similar to Sooma Oy include PrimerDigital, DataSolu, and GlucoModicum.